脑啡肽酶
疾病
心力衰竭
医学
药理学
神经科学
生物信息学
内科学
生物
酶
生物化学
作者
Evgeniya E. Feygina,Alexey G. Katrukha,Alexander G Semenov
出处
期刊:Biokhimiya
[Springer Nature]
日期:2019-11-01
卷期号:84 (11): 1346-1358
被引量:20
标识
DOI:10.1134/s0006297919110105
摘要
Neprilysin (NEP) is a zinc-dependent metalloproteinase that exists in organisms in both transmembrane and soluble forms. NEP substrates are involved in regulating the cardiovascular and nervous systems. In this review, we discuss some of the biochemical characteristics and physiological functions of this enzyme with special emphasis on the use of NEP as a therapeutic target. The history and various physiological aspects of applying NEP inhibitors for treating heart failure and attempts to increase NEP activity when treating Alzheimer's disease using gene and cell therapies are described. Another important issue discussed is the role of NEP as a potential marker for predicting the risk of cardiovascular disease complications. The diagnostic and prognostic performance of soluble NEP in various types of heart failure is analyzed and presented. We also discuss the methods and approaches for measuring NEP activity for prognosis and diagnosis, as well as a possible new role of natriuretic peptides (NEP substrates) in cardiovascular diagnostics.
科研通智能强力驱动
Strongly Powered by AbleSci AI